Analysts expect MaxLinear, Inc. (NYSE:MXL) to announce sales of $114.26 million for the current fiscal quarter, Zacks Investment Research reports. Four analysts have made estimates for MaxLinear’s earnings, with the lowest sales estimate coming in at $114.00 million and the highest estimate coming in at $115.00 million. MaxLinear reported sales of $87.14 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 31.1%. The business is expected to report its next earnings report on Wednesday, February 14th.

On average, analysts expect that MaxLinear will report full year sales of $114.26 million for the current financial year, with estimates ranging from $420.60 million to $426.25 million. For the next year, analysts expect that the company will report sales of $512.82 million per share, with estimates ranging from $508.30 million to $516.10 million. Zacks’ sales averages are an average based on a survey of analysts that follow MaxLinear.

MaxLinear (NYSE:MXL) last posted its quarterly earnings data on Tuesday, November 7th. The semiconductor company reported $0.39 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.33 by $0.06. The business had revenue of $113.58 million during the quarter, compared to the consensus estimate of $115.77 million. MaxLinear had a return on equity of 20.96% and a net margin of 4.73%. The company’s revenue was up 17.9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.43 earnings per share.

MXL has been the subject of several research analyst reports. Zacks Investment Research lowered shares of MaxLinear from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, January 10th. Roth Capital reaffirmed a “buy” rating and issued a $33.00 price objective on shares of MaxLinear in a research report on Friday, December 29th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $32.00 price objective on shares of MaxLinear in a research report on Wednesday, November 8th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have given a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $31.60.

MaxLinear (MXL) traded down $0.90 during mid-day trading on Tuesday, hitting $25.88. The stock had a trading volume of 550,223 shares, compared to its average volume of 485,056. The firm has a market capitalization of $1,760.00, a P/E ratio of 99.54 and a beta of 0.47. MaxLinear has a 1-year low of $20.38 and a 1-year high of $32.47. The company has a debt-to-equity ratio of 0.93, a current ratio of 2.23 and a quick ratio of 1.58.

In other MaxLinear news, insider Daniel Omeniuk sold 760,000 shares of the firm’s stock in a transaction that occurred on Friday, October 20th. The shares were sold at an average price of $0.15, for a total transaction of $114,000.00. Also, VP Brendan Walsh sold 25,018 shares of the firm’s stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $28.00, for a total transaction of $700,504.00. Following the transaction, the vice president now directly owns 155,441 shares of the company’s stock, valued at $4,352,348. The disclosure for this sale can be found here. Insiders sold a total of 2,785,018 shares of company stock valued at $1,134,504 over the last ninety days. 11.92% of the stock is currently owned by insiders.

A number of institutional investors and hedge funds have recently bought and sold shares of MXL. Schwab Charles Investment Management Inc. boosted its holdings in MaxLinear by 7.0% in the second quarter. Schwab Charles Investment Management Inc. now owns 242,533 shares of the semiconductor company’s stock valued at $6,765,000 after purchasing an additional 15,960 shares in the last quarter. Legal & General Group Plc raised its holdings in shares of MaxLinear by 610.0% during the 2nd quarter. Legal & General Group Plc now owns 95,673 shares of the semiconductor company’s stock valued at $2,669,000 after buying an additional 82,198 shares during the period. State Board of Administration of Florida Retirement System raised its holdings in shares of MaxLinear by 86.0% during the 2nd quarter. State Board of Administration of Florida Retirement System now owns 37,111 shares of the semiconductor company’s stock valued at $1,035,000 after buying an additional 17,164 shares during the period. Prudential Financial Inc. raised its holdings in shares of MaxLinear by 800.3% during the 2nd quarter. Prudential Financial Inc. now owns 89,501 shares of the semiconductor company’s stock valued at $2,496,000 after buying an additional 79,560 shares during the period. Finally, Principal Financial Group Inc. raised its holdings in shares of MaxLinear by 3,353.7% during the 2nd quarter. Principal Financial Group Inc. now owns 447,111 shares of the semiconductor company’s stock valued at $12,470,000 after buying an additional 434,165 shares during the period. 88.59% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: “Zacks: Analysts Expect MaxLinear, Inc. (MXL) Will Post Quarterly Sales of $114.26 Million” was reported by American Banking News and is the property of of American Banking News. If you are reading this story on another site, it was illegally copied and reposted in violation of US and international copyright & trademark laws. The correct version of this story can be accessed at https://www.americanbankingnews.com/2018/01/16/zacks-analysts-expect-maxlinear-inc-mxl-will-post-quarterly-sales-of-114-26-million.html.

About MaxLinear

MaxLinear, Inc is a provider of radio frequency (RF) and mixed-signal integrated circuits for cable and satellite broadband communications and the connected home, and wired and wireless infrastructure markets. The Company’s RF receiver products capture and process digital and analog broadband signals to be decoded for various applications.

Get a free copy of the Zacks research report on MaxLinear (MXL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for MaxLinear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxLinear and related companies with MarketBeat.com's FREE daily email newsletter.